Harvested on
Conformis, Inc. to Release Second Quarter 2022 Financial Results on August 8, 202... | https://www.globenewswire.com/news-release/2022/07/05/2474410/36431/en/Conformis-... | BILLERICA, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS... | July 05, 2022 16:30 ET | |
Source:
Conformis, Inc. | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC |
FDA grants Priority Review to Roche’s Lunsumio for people with relapsed or refrac... | https://www.globenewswire.com/news-release/2022/07/06/2474498/0/en/FDA-grants-Pri... | Lunsumio® (mosunetuzumab) could be the first CD20xCD3 T-cell engaging bispecific ... | July 06, 2022 01:00 ET | |
Source:
F. Hoffmann-La Roche Ltd | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC |
Four Genesis HealthCare Professionals Chosen as Future Long-Term and Post-Acute C... | https://www.globenewswire.com/news-release/2022/07/05/2474421/0/en/Four-Genesis-H... | KENNETT SQUARE, Pa., July 05, 2022 (GLOBE NEWSWIRE) -- Genesis HealthCare, one of... | July 05, 2022 16:52 ET | |
Source:
Genesis Administrative Services LLC | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC |
Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-... | https://www.globenewswire.com/news-release/2022/07/06/2474493/0/en/Inmagene-and-H... | SAN DIEGO and SHANGHAI and HONG KONG and SYDNEY, Australia, July 06, 2022 (GLOBE ... | July 06, 2022 00:40 ET | |
Source:
HUTCHMED (China) Limited | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC |
OBI Pharma Announces Discontinuation of the Phase 1/2 Study of its Antibody- OBI ... | https://www.globenewswire.com/news-release/2022/07/05/2474425/0/en/OBI-Pharma-Ann... | TAIPEI, Taiwan, July 05, 2022 (GLOBE NEWSWIRE) -- OBI Pharma, a Taiwan biopharma ... | July 05, 2022 17:00 ET | |
Source:
OBI Pharma Inc. | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC |
OBI Pharma annonce l'arrêt de l'étude de Phase 1/2 portant sur son anticorps OBI ... | https://www.globenewswire.com/news-release/2022/07/05/2474428/0/fr/OBI-Pharma-ann... | TAIPEI, Taïwan, 05 juill. 2022 (GLOBE NEWSWIRE) -- OBI Pharma, une société biopha... | July 05, 2022 17:00 ET | |
Source:
OBI Pharma USA | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC |
OBI Pharma kündigt Abbruch der Phase-1/2-Studie für seinen Antikörper OBI-888 an,... | https://www.globenewswire.com/news-release/2022/07/05/2474428/0/de/OBI-Pharma-k%C... | TAIPEI, Taiwan, July 05, 2022 (GLOBE NEWSWIRE) -- OBI Pharma, ein taiwanesisches ... | July 05, 2022 17:00 ET | |
Source:
OBI Pharma USA | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC |
OBI Pharma 宣佈停止對其抗體 OBI 888 的第 1/2 期研究,以專注於其他優先癌症計劃 | https://www.globenewswire.com/news-release/2022/07/05/2474428/0/zh-hant/OBI-Pharm... | 台灣台北, July 06, 2022 (GLOBE NEWSWIRE) -- 台灣生物製藥公司 OBI Pharma(台灣浩鼎生技)(TPEx: 4174) 今... | July 05, 2022 17:00 ET | |
Source:
OBI Pharma USA | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC |
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | https://www.globenewswire.com/news-release/2022/07/05/2474413/0/en/Olema-Oncology... | SAN FRANCISCO, July 05, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Ol... | July 05, 2022 16:30 ET | |
Source:
Olema Oncology | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC |
台湾浩鼎生技宣布停止其抗体OBI 888的1/2期研究,以专注于其他优先癌症项目 | https://www.globenewswire.com/news-release/2022/07/05/2474428/0/zh-hans/%E5%8F%B0... | 台湾台北, July 06, 2022 (GLOBE NEWSWIRE) -- 台湾生物制药公司浩鼎生技(OBI Pharma,台北证券交易所代码:4174)今天... | July 05, 2022 17:00 ET | |
Source:
OBI Pharma USA | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC | 2022-07-06 05:45:14 UTC |
Sample code snippets to quickly import data set into your application
For more information on how to automatically trigger an import please reference
our WebHook API guide
Integrating with Java
import java.io.BufferedReader;
import java.io.InputStreamReader;
import java.net.URL;
import java.net.URLConnection;
import java.util.Arrays;
public class HelloWorld {
public static void main(String[] args) {
try {
URL urlCSV = new URL(
"https://cache.getdata.io/n108837_44563c761c436f19cf11a58370d83ebfeses/latest_all.csv"
);
URLConnection urlConn = urlCSV.openConnection();
InputStreamReader inputCSV = new InputStreamReader(
((URLConnection) urlConn).getInputStream()
);
BufferedReader br = new BufferedReader(inputCSV);
String line;
String[] fields;
while ((line = br.readLine()) != null) {
// Each row
fields = line.split(",");
System.out.println(Arrays.toString(fields));
}
// clean up buffered reader
br.close();
} catch (Exception e) {
System.out.println(e.getMessage());
}
}
}
Integrating with NodeJs
const csv = require('csv-parser');
const https = require('https');
const fs = require('fs');
const file = fs.createWriteStream("temp_download.csv");
const request = https.get(
"https://cache.getdata.io/n108837_44563c761c436f19cf11a58370d83ebfeses/latest_all.csv",
function(response) {
response.pipe(file);
}
);
file.on('finish', function() {
file.close();
fs.createReadStream('temp_download.csv').pipe(csv()).on('data', (row) => {
// Each row
console.log(row);
}).on('end', () => {
console.log('CSV file successfully processed');
});
});
Integrating with PHP
$data = file_get_contents("https://cache.getdata.io/n108837_44563c761c436f19cf11a58370d83ebfeses/latest_all.csv");
$rows = explode("\n",$data);
$s = array();
foreach($rows as $row) {
# Each row
var_dump( $row);
}
Integrating with Python
import csv
import urllib2
url = 'https://cache.getdata.io/n108837_44563c761c436f19cf11a58370d83ebfeses/latest_all.csv'
response = urllib2.urlopen(url)
cr = csv.reader(response)
for row in cr:
# Each row
print row
Integrating with Ruby
require 'open-uri'
require 'tempfile'
require 'csv'
temp_file = Tempfile.new( "getdata", :encoding => 'ascii-8bit')
temp_file << open("https://cache.getdata.io/n108837_44563c761c436f19cf11a58370d83ebfeses/latest_all.csv").read
temp_file.rewind
CSV.foreach( open(uri), :headers => :first_row ).each do |row|
# Each row
puts row
end